• Written by: (Investorideas.com newswire, breaking stock market
  • Mon, 29 Aug 2022
  •   United States

August 29, 2022 (Investorideas.com Newswire) A small biotech has taken further steps to deepen the intellectual property moat for its potentially revolutionary treatment for alcohol addiction.

Biotech Co. Signs Option Agreement With Drug Co. to Find Ideal Ketamine Formula